By Allison Grande ( May 6, 2010, 6:22 PM EDT) -- A group of health and welfare funds, third-party payors and individual consumers have revamped their putative class action accusing Schering-Plough Corp. of illegally marketing its drugs Intron-A and Temodar for off-label uses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.